CB-1107

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCB-1107
Drug Alias NamehuanbentinibImatinib analog (Liaoning University)CB-1107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transduction pathway inhibitors
TargetsUpdating
Therapy Area/IndicationsGastrointestinal Stromal TumorsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesLiaoning University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLiaoning University
Active IndicationsN/A
Inactive IndicationsGastrointestinal Stromal TumorsLeukemia, Myelogenous, Chronic

Other Information

ATC CodeN/A
Related LinksN/A